The study will be conducted by Janssen image

BMS, Pharmacyclics and Janssen collaborate on cancer

October 14, 2014
Research and Development, Sales and Marketing BMS, Janssen, Pharmacyclics, imbruvica, opdivo

Bristol-Myers Squibb, Pharmacyclics and Janssen are to collaborate on clinical trials combining BMS’s cancer drug Opdivo (nivolumab) with Janssen and …

Colorised transmission electron micrograph of Ebola virus virion

Chinese military-linked firm says it has Ebola cure

October 14, 2014
Medical Communications, Sales and Marketing Ebola, WHO, amms, brincidofovir, sihuan pharmaceutical holdings, tekmira, zmapp

A Chinese drugmaker that has close military ties is seeking fast-track approval for its JK-05 drug that it says can …

NICE releases ‘person-centred’ medicines optimisation guidelines

October 14, 2014
Research and Development, Sales and Marketing ABPI, NHS, NICE, UK, WHO, Whitehead

NICE has recently released the draft of its first guidance on medicines optimisation that it hopes will be more person-centered …

Pfizer breast cancer pill gets FDA nod

October 14, 2014
Research and Development, Sales and Marketing FDA, Femera, LEE011, Pfizer, bemaciclib, breast cancer, palbociclib

Pfizer’s experimental breast cancer drug palbociclib has been accepted and granted a priority review by the US Food and Drug …

jon_linscott

Havas Life Medicom recruits from Pan

October 14, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Jon Linscott, Pan, havas life medicom

Healthcare comms firm Havas Life Medicom has appointed Jon Linscott to its team to serve as a senior director. Linscott …

Hospira image

Hospira recalls drug due to storage hiccup

October 13, 2014
Manufacturing and Production, Sales and Marketing FDA, Hospira, Vancocin, Vancomycin hydrochloride, lilly

Hospira has issued a recall of one lot of its injectable vancomycin hydrochloride in the US due to ‘uncontrolled storage …

Steris image

Steris to buy UK’s Synergy Health for $1.9 billion

October 13, 2014
Manufacturing and Production, Sales and Marketing health, manufacturing, steris, synergy, tax

US-based medical technology firm Steris Corporation is to purchase Synergy Health in the UK for $1.9 billion and will shift …

Iclusig image

EMA keeps Ariad cancer drug on the market

October 13, 2014
Sales and Marketing Ariad, CML, EMA, PRAC, iclusig, leukaemia, ponatinib

The EMA has recommended Ariad’s leukaemia drug Iclusig (ponatinib) should continue to be used under its current indication despite ongoing …

NHS staff striking over pay

October 13, 2014
Medical Communications, Sales and Marketing British Association of Occupational Therapists., GMB, GPs, Hunt, NHS, UCATT, midwives, strike

Over 400,000 NHS staff have gone on strike for four hours as a 1% pay rise requested by Unions was …

carla_stemate_patricell

Patricell appoints sales executive

October 13, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing carla stemate, patricell

Nottingham-based healthcare products firm Patricell is adding Carla Stemate to its team as a sales executive. Based at BioCity, Stemate …

ABPI image

Pharma and transparency: actions speak louder than words

October 13, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS, UK, alltrials, andrew powrie-smith, hcp, transparency

As an industry we continue to deliver innovative, life changing medicines and rewrite the story of many diseases, yet our …

Novartis signs $90m deal with Oxford BioMedica

October 10, 2014
Manufacturing and Production, Research and Development, Sales and Marketing CART-019, Novartis, Oxford BioMedica, immunotherapy, oxb

UK-based biotech Oxford BioMedica is working with Novartis in a transformational deal for the firm worth $90 million to develop …

Endo image

Endo buys Auxilium for $2.6 billion

October 10, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Endo, Testim, Testopel, auxilum

Endo International has agreed a $2.6 billion deal to buy Auxilium Pharmaceuticals in order for the company to gain access …

mary_smiddy

New chief executive for Tonic Life Communications

October 10, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Huntsworth Health, mary smiddy, tonic life communications

Healthcare comms consultancy Tonic Life Communications that is a part of the Huntsworth Health family of agencies, has confirmed the …

tarja_stenvall

AstraZeneca president to lead Sanofi UK

October 9, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Sanofi, Tarja Stenvall

Sanofi has appointed Tarja Stenvall to be its new general manager for the UK and Ireland. Stenvall joins Sanofi from …

Reverse the odds image

Charity launches second cancer research game

October 9, 2014
Medical Communications, Sales and Marketing CRUK, Cancer, amazon, genes in space, oncology, play, reverse the odds

Cancer Research UK has launched its second citizen science game this year called ‘Reverse The Odds’ in an attempt to …

Supervisory board member joins Bayer

October 9, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Otmar Wiestler

Professor Otmar Wiestler has been appointed to the supervisory board at German pharma giant Bayer. He replaces Dr Klaus Kleinfeld …

Ebola image

Texas Ebola victim dies as diseases spreads

October 9, 2014
Medical Communications, Sales and Marketing Chicago O’Hare, Ebola, Hartsfield-Jackson Atlanta, Newark Liberty, Thomas Eric Duncan, UK, US, Washington Dulles

A Liberian national named Thomas Eric Duncan has died in an isolation ward of a Dallas, Texas hospital after being …

Novartis image

Novartis says three executives departing firm

October 9, 2014
Medical Communications, Sales and Marketing Andrin Oswald, Brian McNamara, GSK, George Gunn, Novartis, lilly, oncology, vaccines

Swiss pharma giant Novartis has announced three of its executives are to leave the firm following deals with Lilly and …

stefanie_blasi_rsa_image

RSA makes three appointments

October 9, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mateja Forstnaric, Nicholas Draeger, Stefanie Blasi, rsa

Life sciences executive search and interim management firm RSA has appointed three consultants to its European teams.
  Stefanie Blasi (pictured) …

The Gateway to Local Adoption Series

Latest content